バイオテクノロジーサービスの世界市場レポート 2025年

バイオテクノロジーサービス市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は5.2％で、1,718億7,000万米ドルに成長します。予測期間の成長は、技術の急速な進歩、非感染性疾患の増加、技術革新の重視、農業ベースのバイオテクノロジーサービスの需要増加、合成生物学の需要増加、医薬品研究の開発と改善、個別化治療の成長、コラボレーションとパートナーシップに起因すると考えられます。予測期間における主要動向としては、戦略的提携、クラウド技術によるデータ管理システムの統合、次世代シーケンス技術の開発、臨床検査実施におけるデジタル化技術の適応、自動化ソリューションの導入、人工知能技術の導入、製品やソリューション開発のための合成生物学への投資などが挙げられます。

B型肝炎、糖尿病、がんなどの有病率の増加は、バイオテクノロジー研究に拍車をかけています。バイオテクノロジーでは、生物学や化学の研究ツールを活用して細菌やウイルスの遺伝物質を調べ、病気の原因物質を特定します。バイオファーマ企業の中で、がん研究は最も重要な焦点として際立っています。医療応用の進歩には、モノクローナル抗体を利用した幹細胞治療やゲノム解読が含まれます。例えば、2024年6月、英国の政府機関である国民保健サービス（NHS）は、2023年にイングランドで2型糖尿病を発症する危険性のある人を新たに50万人（54万9,000人）以上特定し、一般開業医（GP）に登録されている非糖尿病性高血糖、または糖尿病予備軍の総数が361万5,330人になったと報告しました。これは、2022年の306万5,825人からの顕著な増加であり、約20％の増加を反映しています。さらに、2024年2月、スイスに本部を置く政府間機関である世界保健機関（WHO）は、2050年までに新たに発生するがん患者は3,500万人を超え、2022年の推定2,000万人に比べ77％増加すると予測しました。その結果、疾患の有病率の上昇と研究開発への多額の投資が、バイオテクノロジーサービス市場の成長を促進すると予想されます。

慢性疾患治療に対応する臨床ソリューションに対する需要の高まりは、バイオテクノロジーサービス市場拡大の重要な促進要因になると考えられます。慢性疾患は、通常3ヶ月以上の長期にわたって持続する持久的な病状を包含します。バイオテクノロジーサービスは、先進治療、精密医療、個々の患者に合わせた標的治療など、慢性疾患を管理するための革新的な臨床ソリューションを提供する上で極めて重要な役割を果たしています。これらの進歩は、慢性疾患の管理と治療成績を大幅に向上させています。例えば、2022年9月の世界保健機関（WHO）の発表によると、慢性疾患は世界の死亡原因の74％を占め、年間死亡者数は4,100万人に達します。その内訳は、心血管疾患が1,790万人、がんが930万人、慢性呼吸器疾患が410万人、糖尿病が200万人となっています。したがって、慢性疾患治療に合わせた臨床ソリューションに対する需要の高まりが、バイオテクノロジーサービス市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のバイオテクノロジーサービス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のバイオテクノロジーサービス市場：成長率分析
• 世界のバイオテクノロジーサービス市場の実績：規模と成長、2019～2024年
• 世界のバイオテクノロジーサービス市場の予測：規模と成長、2024～2029年、2034年
• 世界のバイオテクノロジーサービス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバイオテクノロジーサービス市場：サービス別、実績と予測、2019～2024年、2024～2029年、2034年
• 予防と疾病管理
• 公共エンゲージメント活動
• 健康教育と研究
• 食品バイオテクノロジーサービス
• ドナー募集
• 組織採取
• 細胞の処理と分離
• 研究開発
• 世界のバイオテクノロジーサービス市場：産業別、実績と予測、2019～2024年、2024～2029年、2034年
• 臨床研究機関（CRO）
• 契約製造業者組織（CMO）
• 契約調査製造サービス（CRAMS）
• 世界のバイオテクノロジーサービス市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 製薬
• バイオテクノロジー
• アカデミック
• 臨床検査
• 医療セグメント
• その他
• 世界のバイオテクノロジーサービス市場、予防と疾病管理のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ワクチン接種サービス
• 疾病モニタリング
• 世界のバイオテクノロジーサービス市場、公共エンゲージメント活動のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 啓発キャンペーン
• コミュニティアウトリーチプログラム
• 世界のバイオテクノロジーサービス市場、健康教育と研究のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 医療研修プログラム
• 調査助成金とフェローシップ
• 世界のバイオテクノロジーサービス市場、食品バイオテクノロジーサービスのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 遺伝子組み換え作物サービス
• 食品安全検査
• 世界のバイオテクノロジーサービス市場、ドナー募集のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 献血者募集
• 臓器提供者の募集
• 世界のバイオテクノロジーサービス市場、組織採取のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 血液組織採取
• 生検組織採取
• 世界のバイオテクノロジーサービス市場、細胞処理と分離のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 幹細胞処理
• 免疫細胞の分離
• 世界のバイオテクノロジーサービス市場、研究開発のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 創薬サービス
• 臨床研究

第7章 地域別・国別分析

• 世界のバイオテクノロジーサービス市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のバイオテクノロジーサービス市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオテクノロジーサービス市場：競合情勢
• バイオテクノロジーサービス市場：企業プロファイル
  • Parexel International Corporation
  • Thermo Fisher Scientific
  • Laboratory Corporation of America Holdings
  • IQVIA
  • ICON plc

第31章 その他の大手企業と革新的企業

• Charles River Laboratories
• Syneos Health
• Sartorius AG
• Precision for Medicine Inc.
• Novartis
• Eppendorf Asia Pacific Sdn. Bhd.
• Emmessar BIoTech & Nutrition Ltd
• Vcanbio Cell & Gene Engineering Corp., Ltd
• Ke Rui Gene
• Absea BIoTechnology Ltd
• CStone Pharm-B
• Daiichi Sankyo
• bitBiome
• Taisho Pharmaceutical
• AGC Biologics

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• バイオテクノロジーサービス市場、2029年：新たな機会を提供する国
• バイオテクノロジーサービス市場、2029年：新たな機会を提供するセグメント
• バイオテクノロジーサービス市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Biotechnology services involve the modification of living microorganisms to produce customized biotechnology products for medical, pharmaceutical, and scientific laboratories on a contract or custom basis. These services contribute to the development of breakthrough products and technologies aimed at addressing diseases, environmental concerns, hunger, energy efficiency, and cleaner industrial processes.

Key types of biotechnology services include prevention and disease control, public engagement activities, health education and research, food biotechnology services, donor recruitment, tissue collection, cell processing and isolation, and research and development. Food biotechnology services cover various technologies applied in crops, livestock, forestry, fisheries, aquaculture, and agro-industry. These services are utilized for genetic improvement, conservation of genetic resources, disease diagnosis, vaccine development, and fermented food production. Applications of biotechnology services span the pharmaceutical, biotechnological, academic, clinical trial, and healthcare sectors, with usage by Clinical Research Organizations (CROs), Contract Manufacturers Organizations (CMOs), and Contract Research and Manufacturing Services (CRAMS).

The biotechnology services market research report is one of a series of new reports from The Business Research Company that provides biotechnology services market statistics, including biotechnology services industry global market size, regional shares, competitors with a biotechnology services market share, detailed biotechnology services market segments, market trends and opportunities, and any further data you may need to thrive in the biotechnology services industry. This biotechnology services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biotechnology services market size has grown steadily in recent years. It will grow from $133.74 billion in 2024 to $140.24 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to strong economic growth in emerging markets, increased collaborations with other research institutes and companies, and increased demand for food.

The biotechnology services market size is expected to see strong growth in the next few years. It will grow to $171.87 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to the rapid advancements in technology, rising non-communicable diseases, emphasis on innovation, rising demand for agriculture-based biotechnology services, growing demand for synthetic biology, developments and improvements in drug research, growth in personalized treatment, and collaboration and partnership. Major trends in the forecast period include strategic collaborations, integrating data management systems through cloud technology, development of next-generation sequencing technology, adapting digitalizing techniques in conducting clinical trials, implementing automated solutions, deploying artificial intelligence technologies, and investment in synthetic biology to develop products and solutions.

The growing prevalence of conditions such as hepatitis B, diabetes, and cancer is fueling biotechnology research. Biotechnology utilizes research tools from biology and chemistry to examine the genetic material of bacteria and viruses to identify disease-causing agents. Among biopharma companies, oncology research stands out as the most significant focus. Advances in medical applications include stem cell treatments utilizing monoclonal antibodies and genome sequencing. For example, in June 2024, the National Health Service (NHS), a UK-based government department, reported that in 2023, it identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, raising the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a general practitioner (GP) to 3,615,330. This marks a notable increase from 3,065,825 in 2022, reflecting a rise of nearly 20%. Additionally, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, projected that by 2050, there would be over 35 million new cancer cases, representing a 77% increase compared to an estimated 20 million cases in 2022. Consequently, the rising prevalence of diseases and significant investments in R&D are expected to drive growth in the biotechnology services market.

The escalating demand for clinical solutions catering to chronic disease treatments is set to be a significant driver for the expansion of the biotechnology services market. Chronic diseases encompass enduring medical conditions persisting for an extended duration, typically three months or more. Biotechnology services play a pivotal role in offering innovative clinical solutions for managing chronic diseases, including advanced therapies, precision medicine, and targeted treatments personalized to individual patients. These advancements significantly enhance the management and outcomes of chronic ailments. For instance, as per the World Health Organization (WHO) in September 2022, chronic diseases account for 74% of global deaths, amounting to 41 million fatalities annually. This includes 17.9 million deaths attributed to cardiovascular diseases, 9.3 million to cancer, 4.1 million to chronic respiratory diseases, and 2.0 million to diabetes. Hence, the mounting demand for clinical solutions tailored to chronic disease treatment is a driving force behind the growth of the biotechnology services market.

Collaborations and partnerships among industry players are increasingly becoming a trend in the biotech services sector. For example, in April 2024, ICL Partners, an Israel-based manufacturing company, joined forces with Ideelab Biotechnology, a Brazil-based biotechnology firm, to expedite the development of innovative biological technologies for agriculture, with an emphasis on sustainable and regenerative solutions. By harnessing Ideelab's expertise in advanced biologicals alongside ICL's leadership in plant nutrition and physiology, the partnership aims to develop next-generation products that tackle global agricultural challenges and improve food production.

Key companies within the biotechnology services market are dedicated to pioneering innovative therapies, such as biomarker algorithms for the primary treatment of patients with non-small cell lung cancer (NSCLC). Biomarker algorithms encompass mathematical or computational models integrating data from multiple biological indicators to provide comprehensive assessments of specific medical conditions. For instance, in April 2023, Strata Oncology Inc., a US-based precision oncology company, introduced Strata Select-a groundbreaking molecular profiling test for advanced cancer patients. Noteworthy for being the first immunotherapy biomarker algorithm covered by Medicare across solid tumors, Strata Select empowers oncologists to make more informed treatment decisions, thereby enhancing patient outcomes.

In December 2023, Eli Lilly and Company, a US-based pharmaceutical firm, acquired POINT Biopharma Global Inc. for an undisclosed sum. This strategic acquisition aims to enhance Lilly's oncology expertise, particularly in advanced radioligand therapies designed to treat various forms of cancer. POINT Biopharma Global Inc. is a US-based biotechnology company recognized for its innovative methods in cancer treatment.

Major companies operating in the biotechnology services market include Parexel International Corporation, Thermo Fisher Scientific, Laboratory Corporation of America Holdings, IQVIA, ICON plc, Charles River Laboratories, Syneos Health, Sartorius AG, Precision for Medicine Inc., Novartis, Eppendorf Asia Pacific Sdn. Bhd., Emmessar Biotech & Nutrition Ltd, Vcanbio Cell & Gene Engineering Corp., Ltd, Ke Rui Gene, Absea Biotechnology Ltd, CStone Pharm-B, Daiichi Sankyo, bitBiome, Taisho Pharmaceutical, AGC Biologics, Hamamatsu Pharma Research, Artios Pharma, AstraZeneca, Bio Products Laboratory (BPL), Cambridge Bioscience, Shire Pharmaceuticals Ltd, BTG Ltd, eXmoor Pharma, 4D Pharma PLC, Touchlight Genetics, Ophidia Medical Technologies, ATAI Life Sciences, Phaseform, Evotec, Sanity Group, Primmbiotech Vaccitech, Biolat, Asla-Biotech, Genera, Anima Lab, Silvanols, OU TBD-Biodiscovery, Qvalitas Arstikeskus AS, Concise Systems OU, GPE Globalpharma OU, Belarusian National Biotechnology Corporation, Innothera, Olainfarm, Pharmaidea, Amgen Inc., Gilead Sciences, Celgene Corporation, Biogen Inc., Vertex Pharmaceuticals, Illumina, Inc., Regeneron Pharmaceuticals Inc., Alexion Pharmaceuticals, Hemostemix Inc., Resverlogix Corporation, Zenith Epigenetics Corp., Bayer, AMEGA Biotech, Pierre Fabre, Pfizer, Quantificare, Apsen Farmaceutica, BioMarin Pharmaceutical, DK Diagnostics, Biosonda Biotechnology, Laboratorios Legrand, Biomerics, Julphar Pharmaceuticals, Medpharma, Pharmax, Neopharma, City Breeze Technical Services, CinnaGen, BioSun Pharmed, AryoGen Pharmed, 4Clinics, 54gene, Amoun, Aspen Pharmacare, BBI Solutions, BioTech Africa, ClinArt MENA, Crux Pharmaceuticals, Genesis Pharmaceuticals, Massive Genomics, Mayne Pharma, Sanofi Genzyme, Teleflex Medical, The Micron Group

Asia-Pacific was the largest region in the biotechnology services market in 2024. North America was the second largest region in the global biotechnology services market analysis. The regions covered in the biotechnology services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biotechnology services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The biotechnology services market consists of revenue earned by entities that engage in conducting research and experimental development in biotechnology. Numerous global issues are helped by biotechnology, including infectious diseases, ageing societies, food security, energy security, and climate change, to name a few. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biotechnology Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biotechnology services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biotechnology services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biotechnology services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Service: Prevention And Disease Control, Public Engagement Activities, Health Education And Research, Food Biotechnology Services, Donor Recruitment, Tissue Collection, Cell Processing And Isolation, Research And Development
• 2) By Industry: Clinical Research Organizations (CROS), Contract Manufacturers Organizations (CMOS), And Contract Research And Manufacturing Services (CRAMS)
• 3) By Area Of Application: Pharmaceutical, Biotechnology, Academic, Clinical Trial, Healthcare Sectors, Others
• Subsegments:
• 1) By Prevention And Disease Control: Vaccination Services; Disease Surveillance
• 2) By Public Engagement Activities: Awareness Campaigns; Community Outreach Programs
• 3) By Health Education And Research: Medical Training Programs; Research Grants And Fellowships
• 4) By Food Biotechnology Services: Genetically Modified Crop Services; Food Safety Testing
• 5) By Donor Recruitment: Blood Donor Recruitment; Organ Donor Recruitment
• 6) By Tissue Collection: Blood Tissue Collection; Biopsy Tissue Collection
• 7) By Cell Processing And Isolation: Stem Cell Processing; Immune Cell Isolation
• 8) By Research And Development: Drug Discovery Services; Clinical Research
• Companies Mentioned: Parexel International Corporation; Thermo Fisher Scientific; Laboratory Corporation of America Holdings; IQVIA; ICON plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biotechnology Services Market Characteristics

3. Biotechnology Services Market Trends And Strategies

4. Biotechnology Services Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Biotechnology Services Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biotechnology Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biotechnology Services Market Growth Rate Analysis
• 5.4. Global Biotechnology Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biotechnology Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biotechnology Services Total Addressable Market (TAM)

6. Biotechnology Services Market Segmentation

• 6.1. Global Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prevention And Disease Control
• Public Engagement Activities
• Health Education And Research
• Food Biotechnology Services
• Donor Recruitment
• Tissue Collection
• Cell Processing And Isolation
• Research And Development
• 6.2. Global Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Research Organizations (CROs)
• Contract Manufacturers Organizations (CMOs)
• Contract Research And Manufacturing Services (CRAMS)
• 6.3. Global Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical
• Biotechnology
• Academic
• Clinical Trial
• Healthcare Sectors
• Others
• 6.4. Global Biotechnology Services Market, Sub-Segmentation Of Prevention And Disease Control, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccination Services
• Disease Surveillance
• 6.5. Global Biotechnology Services Market, Sub-Segmentation Of Public Engagement Activities, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Awareness Campaigns
• Community Outreach Programs
• 6.6. Global Biotechnology Services Market, Sub-Segmentation Of Health Education And Research, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical Training Programs
• Research Grants And Fellowships
• 6.7. Global Biotechnology Services Market, Sub-Segmentation Of Food Biotechnology Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetically Modified Crop Services
• Food Safety Testing
• 6.8. Global Biotechnology Services Market, Sub-Segmentation Of Donor Recruitment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Donor Recruitment
• Organ Donor Recruitment
• 6.9. Global Biotechnology Services Market, Sub-Segmentation Of Tissue Collection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Tissue Collection
• Biopsy Tissue Collection
• 6.10. Global Biotechnology Services Market, Sub-Segmentation Of Cell Processing And Isolation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stem Cell Processing
• Immune Cell Isolation
• 6.11. Global Biotechnology Services Market, Sub-Segmentation Of Research And Development, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery Services
• Clinical Research

7. Biotechnology Services Market Regional And Country Analysis

• 7.1. Global Biotechnology Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biotechnology Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biotechnology Services Market

• 8.1. Asia-Pacific Biotechnology Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biotechnology Services Market

• 9.1. China Biotechnology Services Market Overview
• 9.2. China Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biotechnology Services Market

• 10.1. India Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biotechnology Services Market

• 11.1. Japan Biotechnology Services Market Overview
• 11.2. Japan Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biotechnology Services Market

• 12.1. Australia Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biotechnology Services Market

• 13.1. Indonesia Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biotechnology Services Market

• 14.1. South Korea Biotechnology Services Market Overview
• 14.2. South Korea Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biotechnology Services Market

• 15.1. Western Europe Biotechnology Services Market Overview
• 15.2. Western Europe Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biotechnology Services Market

• 16.1. UK Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biotechnology Services Market

• 17.1. Germany Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biotechnology Services Market

• 18.1. France Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biotechnology Services Market

• 19.1. Italy Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biotechnology Services Market

• 20.1. Spain Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biotechnology Services Market

• 21.1. Eastern Europe Biotechnology Services Market Overview
• 21.2. Eastern Europe Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biotechnology Services Market

• 22.1. Russia Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biotechnology Services Market

• 23.1. North America Biotechnology Services Market Overview
• 23.2. North America Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biotechnology Services Market

• 24.1. USA Biotechnology Services Market Overview
• 24.2. USA Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biotechnology Services Market

• 25.1. Canada Biotechnology Services Market Overview
• 25.2. Canada Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biotechnology Services Market

• 26.1. South America Biotechnology Services Market Overview
• 26.2. South America Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biotechnology Services Market

• 27.1. Brazil Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biotechnology Services Market

• 28.1. Middle East Biotechnology Services Market Overview
• 28.2. Middle East Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biotechnology Services Market

• 29.1. Africa Biotechnology Services Market Overview
• 29.2. Africa Biotechnology Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biotechnology Services Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biotechnology Services Market, Segmentation By Area Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biotechnology Services Market Competitive Landscape And Company Profiles

• 30.1. Biotechnology Services Market Competitive Landscape
• 30.2. Biotechnology Services Market Company Profiles
  • 30.2.1. Parexel International Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. IQVIA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. ICON plc Overview, Products and Services, Strategy and Financial Analysis

31. Biotechnology Services Market Other Major And Innovative Companies

• 31.1. Charles River Laboratories
• 31.2. Syneos Health
• 31.3. Sartorius AG
• 31.4. Precision for Medicine Inc.
• 31.5. Novartis
• 31.6. Eppendorf Asia Pacific Sdn. Bhd.
• 31.7. Emmessar Biotech & Nutrition Ltd
• 31.8. Vcanbio Cell & Gene Engineering Corp., Ltd
• 31.9. Ke Rui Gene
• 31.10. Absea Biotechnology Ltd
• 31.11. CStone Pharm-B
• 31.12. Daiichi Sankyo
• 31.13. bitBiome
• 31.14. Taisho Pharmaceutical
• 31.15. AGC Biologics

32. Global Biotechnology Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biotechnology Services Market

34. Recent Developments In The Biotechnology Services Market

35. Biotechnology Services Market High Potential Countries, Segments and Strategies

• 35.1 Biotechnology Services Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biotechnology Services Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biotechnology Services Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer